A genome-wide association study identifies novel loci associated with circulating IGF-I and IGFBP-3
Open Access
- 7 January 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 20 (6), 1241-1251
- https://doi.org/10.1093/hmg/ddq560
Abstract
Insulin-like growth factor-I (IGF-I) and insulin-like growth factor-binding protein-3 (IGFBP-3) are involved in cell replication, proliferation, differentiation, protein synthesis, carbohydrate homeostasis and bone metabolism. Circulating IGF-I and IGFBP-3 concentrations predict anthropometric traits and risk of cancer and cardiovascular disease. In a genome-wide association study of 10 280 middle-aged and older men and women from four community-based cohort studies, we confirmed a known association of single nucleotide polymorphisms in the IGFBP3 gene region on chromosome 7p12.3 with IGFBP-3 concentrations using a significance threshold of P < 5 × 10−8 (P = 3.3 × 10−101). Furthermore, the same IGFBP3 gene locus (e.g. rs11977526) that was associated with IGFBP-3 concentrations was also associated with the opposite direction of effect, with IGF-I concentration after adjustment for IGFBP-3 concentration (P = 1.9 × 10−26). A novel and independent locus on chromosome 7p12.3 (rs700752) had genome-wide significant associations with higher IGFBP-3 (P = 4.4 × 10−21) and higher IGF-I (P = 4.9 × 10−9) concentrations; when the two measurements were adjusted for one another, the IGF-I association was attenuated but the IGFBP-3 association was not. Two additional loci demonstrated genome-wide significant associations with IGFBP-3 concentration (rs1065656, chromosome 16p13.3, P = 1.2 × 10−11, IGFALS, a confirmatory finding; and rs4234798, chromosome 4p16.1, P = 4.5 × 10−10, SORCS2, a novel finding). Together, the four genome-wide significant loci explained 6.5% of the population variation in IGFBP-3 concentration. Furthermore, we observed a borderline statistically significant association between IGF-I concentration and FOXO3 (rs2153960, chromosome 6q21, P = 5.1 × 10−7), a locus associated with longevity. These genetic loci deserve further investigation to elucidate the biological basis for the observed associations and clarify their possible role in IGF-mediated regulation of cell growth and metabolism.Keywords
This publication has 48 references indexed in Scilit:
- SORCS1: A Novel Human Type 2 Diabetes Susceptibility Gene Suggested by the MouseDiabetes, 2007
- Effects of rehabilitative exercise on peripheral muscle TNF , IL-6, IGF-I and MyoD expression in patients with COPDThorax, 2007
- Utility of Free IGF-I MeasurementsPituitary, 2007
- Deficiency of the Circulating Insulin-like Growth Factor System Associated with Inactivation of the Acid-Labile Subunit GeneNew England Journal of Medicine, 2004
- Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart StudyAmerican Journal Of Medicine, 2003
- Cardiovascular Function in AcromegalyEndocrine Reviews, 2003
- Low Serum Insulin-Like Growth Factor I Is Associated With Increased Risk of Ischemic Heart DiseaseCirculation, 2002
- Full genome screen for Alzheimer disease: Stage II analysis*American Journal of Medical Genetics, 2002
- Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populationsDiabetologia, 2001
- Insulin-Like Growth FactorsNew England Journal of Medicine, 1997